Gene · 3597
Papers1,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The ins and outs of innate and adaptive type 2 immunity. | Immunity | 2023 | 37044061 | PubTator, text mining | PubMed |
| Tailored treatments in inborn errors of immunity associated with atopy (IEIs-A) with skin involvement. | Front Pediatr | 2023 | 37033173 | PubTator, text mining | PubMed |
| CRISPR/Cas9-engineering of HMC-1.2 cells renders a human mast cell line with a single D816V-KIT mutation: An improved preclinical model for research on mastocytosis. | Front Immunol | 2023 | 37025992 | PubTator, text mining | PubMed |
| Design of cell-type-specific hyperstable IL-4 mimetics via modular de novo scaffolds. | Nat Chem Biol | 2023 | 37024727 | PubTator, text mining | PubMed |
| IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia. | Haematologica | 2023 | 37021528 | PubTator, text mining | PubMed |
| The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. | Front Immunol | 2023 | 37020537 | PubTator, text mining | PubMed |
| Concerted Antibody and Antigen Discovery by Differential Whole-cell Phage Display Selections and Multi-omic Target Deconvolution. | J Mol Biol | 2023 | 37019174 | PubTator, text mining | PubMed |
| Repetitive schistosoma exposure causes perivascular lung fibrosis and persistent pulmonary hypertension. | Clin Sci (Lond) | 2023 | 37014925 | PubTator, text mining | PubMed |
| Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective Study. | Clin Drug Investig | 2023 | 37012527 | PubTator, text mining | PubMed |
| Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature. | Front Mol Neurosci | 2023 | 37008787 | PubTator, text mining | PubMed |
| Clinical trials using dental stem cells: 2022 update. | World J Stem Cells | 2023 | 37007456 | PubTator, text mining | PubMed |
| Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis. | Front Immunol | 2023 | 37006267 | PubTator, text mining | PubMed |
| Assessment of local and systemic signature of eosinophilic esophagitis (EoE) in children through multi-omics approaches. | Front Immunol | 2023 | 37006253 | PubTator, text mining | PubMed |
| Targeting interleukin 4 and interleukin 13: a novel therapeutic approach in bullous pemphigoid. | Ann Med | 2023 | 36999962 | PubTator, text mining | PubMed |
| POSTRE: a tool to predict the pathological effects of human structural variants. | Nucleic Acids Res | 2023 | 36999617 | PubTator, text mining | PubMed |
| Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages. | J Exp Med | 2023 | 36995340 | PubTator, text mining | PubMed |
| AlphaFold2 enables accurate deorphanization of ligands to single-pass receptors. | bioRxiv | 2023 | 36993313 | PubTator, text mining | PubMed |
| Repurposing Astragalus Polysaccharide PG2 for Inhibiting ACE2 and SARS-CoV-2 Spike Syncytial Formation and Anti-Inflammatory Effects. | Viruses | 2023 | 36992350 | PubTator, text mining | PubMed |
| Carbon Nanotube-Based Intumescent Flame Retardants Achieve High-Efficiency Flame Retardancy and Simultaneously Avoid Mechanical Property Loss. | Polymers (Basel) | 2023 | 36987187 | PubTator, text mining | PubMed |
| Atopic Dermatitis and Ulcerative Colitis Successfully Treated with Upadacitinib. | Medicina (Kaunas) | 2023 | 36984542 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3597/papers?page=13